Pulmatrix - Stock Price History | PULM

Historical daily share price chart and data for Pulmatrix since 2021 adjusted for splits. The latest closing stock price for Pulmatrix as of October 22, 2021 is 0.70.
  • The all-time high Pulmatrix stock closing price was 181.25 on March 21, 2014.
  • The Pulmatrix 52-week high stock price is 3.04, which is 334.3% above the current share price.
  • The Pulmatrix 52-week low stock price is 0.68, which is 2.9% below the current share price.
  • The average Pulmatrix stock price for the last 52 weeks is 1.11.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pulmatrix Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 1.3754 1.6200 1.9700 0.9176 1.1900 38.37%
2019 1.1006 2.7000 3.2830 0.6800 0.8600 -64.18%
2018 6.7152 14.2000 19.9000 2.4010 2.4010 -82.97%
2017 23.5015 5.9990 51.0000 5.5100 14.1000 138.98%
2016 20.9869 38.3000 42.5000 5.6000 5.9000 -85.95%
2015 75.4266 88.0000 126.5000 34.1000 42.0000 -52.00%
2014 136.6268 181.2500 181.2500 84.0000 87.5000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.039B $0.013B
Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76